[Federal Register Volume 85, Number 155 (Tuesday, August 11, 2020)]
[Notices]
[Pages 48563-48564]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17437]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-697]


Importer of Controlled Substances Application: GE Healthcare

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: GE Healthcare applied to be registered as an importer of the 
following basic class(es) of a controlled substance: Cocaine.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before September 10, 
2020. Such persons may also file a written request for a hearing on the 
application on or before September 10, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

[[Page 48564]]


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on July 20, 2020, GE Healthcare, 3350 North Ridge 
Avenue, Arlington Heights, Illinois 60004-1412, applied to be 
registered as an importer of the following basic class(es) of a 
controlled substance:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Cocaine................................     9041  II
------------------------------------------------------------------------

    The company plans to import small quantities of Ioflupane, in the 
form of three separate analogues of cocaine, to validate production and 
quality control systems, for a reference standard, and for producing 
material for a future investigational new drug submission. Supplies of 
this particular controlled substances are not available in the form 
needed within the current domestic supply of the United States.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-17437 Filed 8-10-20; 8:45 am]
BILLING CODE 4410-09-P